Antibody association in solution: cluster distributions and mechanisms

References

• El Abd Y, Tabll A, Smolic R, Smolic M. Mini-review: the market growth of diagnostic and therapeutic monoclonal antibodies – SARS CoV-2 as an example. Hum Antibodies. 2022;30(1):15–9. doi:10.3233/HAB-211513.
   PubMedGoogle Scholar
• Li W, Prabakaran P, Zao Chen W, Zhu Z, Feng Y, Dimitrov DS. Antibody aggregation: insights from sequence and structure. Antibodies. 2016;5(3):19. doi:10.3390/antib5030019.
   Google Scholar
• Anselmo AC, Mitragotri S. An overview of clinical and commercial impact of drug delivery systems. J Control Release. 2014;190:15–28. doi:10.1016/j.jconrel.2014.03.053.
   PubMed Web of Science ®Google Scholar
• Roberts CJ. Protein aggregation and its impact on product quality. Curr Opin Biotechnol. 2014;30:211–17. doi:10.1016/j.copbio.2014.08.001.
   PubMed Web of Science ®Google Scholar
• Kanai S, Liu J, Patapoff TW, Shire SJ. Reversible self-association of a concentrated monoclonal antibody solution mediated by fab–fab interaction that impacts solution viscosity. J Pharm Sci. 2008;97(10):4219–27. doi:10.1002/jps.21322.
   PubMed Web of Science ®Google Scholar
• Page S, Khan T, Kühl P, Schwach G, Storch K, Chokshi H. Patient centricity driving formulation innovation: improvements in patient care facilitated by novel therapeutics and drug delivery technologies. Annu Rev Pharmacol Toxicol. 2022;62(1):341–63. PMID: 34990203. doi: 10.1146/annurev-pharmtox-052120-093517.
   PubMedGoogle Scholar
• Meyer RM, Berger L, Nerkamp J, Scheler S, Nehring S, Friess W. Identification of monoclonal antibody variants involved in aggregate formation – part 1: charge variants. Eur J Pharm Biopharm. 2021;158:123–31. doi:10.1016/j.ejpb.2020.10.020.
   PubMed Web of Science ®Google Scholar
• Meyer RM, Berger L, Nerkamp J, Scheler S, Nehring S, Friess W. Identification of monoclonal antibody variants involved in aggregate formation – part 2: hydrophobicity variants. Eur J Pharm Biopharm. 2021;160:134–42. doi:10.1016/j.ejpb.2021.01.006.
   PubMed Web of Science ®Google Scholar
• Woldeyes MA, Qi W, Razinkov VI, Furst EM, Roberts C. How well do low- and high-concentration protein interactions predict solution viscosities of monoclonal antibodies? J Pharm Sci. 2019;108(1):142–54. doi:10.1016/j.xphs.2018.07.007.
   PubMed Web of Science ®Google Scholar
• Sharma VK, Patapoff TW, Kabakoff B, Pai S, Hilario E, Zhang B, Li C, Borisov O, Kelley RF, Chorny I. et al. In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability. Proc Natl Acad Sci USA. 2014;111(52):18601–06. doi:10.1073/pnas.1421779112.
   PubMed Web of Science ®Google Scholar
• Sankar K, K SR Jr., Carl SM, Day T, Maier JKX. AggScore: prediction of aggregation-prone regions in proteins based on the distribution of surface patches. Proteins. 2018;86(11):1147–56. doi:10.1002/prot.25594.
   PubMed Web of Science ®Google Scholar
• Kuroda D, Tsumoto K. Engineering stability, viscosity, and immunogenicity of antibodies by computational design. J Pharm Sci. 2020;109(5):1631–51. doi:10.1016/j.xphs.2020.01.011.
   PubMed Web of Science ®Google Scholar
• Calero-Rubio C, Saluja A, Sahin E, Roberts CJ. Predicting high-concentration interactions of monoclonal antibody solutions: comparison of theoretical approaches for strongly attractive versus repulsive conditions. J Phys Chem B. 2019;123(27):5709–20. doi:10.1021/acs.jpcb.9b03779.
   PubMed Web of Science ®Google Scholar
• Yadav S, Shire SJ, Kalonia DS. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. J Pharm Sci. 2010;99(12):4812–29. doi:10.1002/jps.22190.
   PubMed Web of Science ®Google Scholar
• Ferreira GM, Shahfar H, Sathish HA, R RL Jr., Roberts CJ. Identifying key residues that drive strong electrostatic attractions between therapeutic antibodies. J Phys Chem B. 2019;123(50):10642–53. doi:10.1021/acs.jpcb.9b08355.
   PubMed Web of Science ®Google Scholar
• Shahfar H, Forder JK, Roberts CJ. Toward a suite of coarse-grained models for molecular simulation of monoclonal antibodies and therapeutic proteins. J Phys Chem B. 2021;125(14):3574–88. doi:10.1021/acs.jpcb.1c01903.
   PubMed Web of Science ®Google Scholar
• Chowdhury A, Bollinger JA, Dear BJ, Cheung JK, Johnston KP, Truskett TM. Coarse-grained molecular dynamics simulations for understanding the impact of short-range anisotropic attractions on structure and viscosity of concentrated monoclonal antibody solutions. Mol Pharmaceutics. 2020;17(5):1748–56. doi:10.1021/acs.molpharmaceut.9b00960.
   PubMed Web of Science ®Google Scholar
• Lanzaro A, Roche A, Sibanda N, Corbett D, Davis P, Shah M, Pathak JA, Uddin S, van der Walle CF, Yuan X-F. et al. Cluster percolation causes shear thinning behavior in concentrated solutions of monoclonal antibodies. Mol Pharmaceutics. 2021;18(7):2669–82. doi:10.1021/acs.molpharmaceut.1c00198.
   PubMed Web of Science ®Google Scholar
• Calero-Rubio C, S A, Roberts CJ. Coarse-grained antibody models for “weak” protein–protein interactions from low to high concentrations. J Phys Chem B. 2016;120(27):6592–605. doi:10.1021/acs.jpcb.6b04907.
   PubMed Web of Science ®Google Scholar
• Chowdhury A, Guruprasad G, Chen AT, Karouta CA, Blanco MA, Truskett TM, Johnston KP. Protein-protein interactions, clustering, and rheology for bovine IgG up to high concentrations characterized by small angle X-Ray scattering and molecular dynamics simulations. J Pharm Sci. 2020;109(1):696–708. doi:10.1016/j.xphs.2019.11.001.
   PubMed Web of Science ®Google Scholar
• Skar-Gislinge N, Ronti M, Garting T, Rischel C, Schurtenberger P, Zaccarelli E, Stradner A. A colloid approach to self-assembling antibodies. Mol Pharmaceutics. 2019;16(6):2394–404. doi:10.1021/acs.molpharmaceut.9b00019.
   PubMed Web of Science ®Google Scholar
• Ferreira GM, Calero-Rubio C, Sathish HA, R RL Jr., Roberts CJ. Electrostatically mediated protein-protein interactions for monoclonal antibodies: a combined experimental and coarse-grained molecular modeling approach. J Pharm Sci. 2019;108(1):120–32. doi:10.1016/j.xphs.2018.11.004.
   PubMed Web of Science ®Google Scholar
• Izadi S, Patapoff TW, Walters BT. Multiscale coarse-grained approach to investigate self-association of antibodies. Biophys J. 2020;118(11):2741–54. doi:10.1016/j.bpj.2020.04.022.
   PubMed Web of Science ®Google Scholar
• Chaudhri A, Zarraga IE, Kamerzell TJ, Brandt JP, Patapoff TW, Shire SJ, Voth GA. Coarse-grained modeling of the self-association of therapeutic monoclonal antibodies. J Phys Chem B. 2012;116(28):8045–57. doi:10.1021/jp301140u.
   PubMed Web of Science ®Google Scholar
• Kastelic M, Kalyuzhnyi YV, Hribar-Lee B, Dill KA, Vlachy V. Protein aggregation in salt solutions. Proc Natl Acad Sci USA. 2015;112(21):6766–70. doi:10.1073/pnas.1507303112.
   PubMed Web of Science ®Google Scholar
• Kastelic M, Kalyuzhnyi YV, Vlachy V. Modeling phase transitions in mixtures of β–γ lens crystallins. Soft Matter. 2016;12(35):7289–98. doi:10.1039/C6SM01513A.
   PubMed Web of Science ®Google Scholar
• Kastelic M, Dill KA, Kalyuzhnyi YV, Vlachy V. Controlling the viscosities of antibody solutions through control of their binding sites. J Mol Liq. 2018;270:234–42. Modern trends in theory of electrolyte solutions. In memory of Lesser Blum. doi:10.1016/j.molliq.2017.11.106.
   PubMed Web of Science ®Google Scholar
• Wertheim MS. Fluids of dimerizing hard spheres, and fluid mixtures of hard spheres and dispheres. J Chem Phys. 1986;85(5):2929–36. doi:10.1063/1.451002.
   Web of Science ®Google Scholar
• Brudar S, Hribar-Lee B. Effect of buffer on protein stability in aqueous solutions: a simple protein aggregation model. J Phys Chem B. 2021;125(10):2504–12. doi:10.1021/acs.jpcb.0c10339.
   PubMed Web of Science ®Google Scholar
• Gentiluomo L, Roessner D, Streicher W, Mahapatra S, Harris P, Frieß W. Characterization of native reversible self-association of a monoclonal antibody mediated by fab-fab interaction. J Pharm Sci. 2020;109(1):443–51. doi:10.1016/j.xphs.2019.09.021.
   PubMed Web of Science ®Google Scholar
• Lebowitz J, Lewis MS, Schuck P. Modern analytical ultracentrifugation in protein science: A tutorial review. Protein Sci. 2002;11(9):2067–79. doi:10.1110/ps.0207702.
   PubMed Web of Science ®Google Scholar
• Dear BJ, Bollinger JA, Chowdhury A, Hung JJ, Wilks LR, Karouta CA, Ramachandran K, Shay TY, Nieto MP, Sharma A. et al. X-ray scattering and coarse-grained simulations for clustering and interactions of monoclonal antibodies at high concentrations. J Phys Chem B. 2019;123(25):5274–90. doi:10.1021/acs.jpcb.9b04478.
   PubMed Web of Science ®Google Scholar
• Hung JJ, Dear BJ, Karouta CA, Chowdhury AA, Godfrin PD, Bollinger JA, Nieto MP, Wilks LR, Shay TY, Ramachandran K. et al. Protein–protein interactions of highly concentrated monoclonal antibody solutions via static light scattering and influence on the viscosity. J Phys Chem B. 2019;123(4):739–55. doi:10.1021/acs.jpcb.8b09527.
   PubMed Web of Science ®Google Scholar
• Chowdhury A, Manohar N, Guruprasad G, Chen AT, Lanzaro A, Blanco M, Johnston KP, Truskett TM. Characterizing experimental monoclonal antibody interactions and clustering using a coarse-grained simulation library and a viscosity model. J Phys Chem B. 2023;127(5):1120–37. doi:10.1021/acs.jpcb.2c07616.
   PubMed Web of Science ®Google Scholar
• Mooney M. The viscosity of a concentrated suspension of spherical particles. J Colloid Sci. 1951;6(2):162–70. doi:10.1016/0095-8522(51)90036-0.
   Google Scholar
• Lazzari S, Nicoud L, Jaquet B, Lattuada M, Morbidelli M. Fractal-like structures in colloid science. Adv Colloid Interface Sci. 2016;235:1–13. doi:10.1016/j.cis.2016.05.002.
   PubMed Web of Science ®Google Scholar
• Roche A, Gentiluomo L, Sibanda N, Roessner D, Friess W, Trainoff SP, Curtis R. Towards an improved prediction of concentrated antibody solution viscosity using the Huggins coefficient. J Colloid Interface Sci. 2022;607:1813–24. doi:10.1016/j.jcis.2021.08.191.
   PubMed Web of Science ®Google Scholar
• Pindrus MA, Shire SJ, Yadav S, Kalonia DS. Challenges in determining intrinsic viscosity under low ionic strength solution conditions. Pharm Res. 2017;34(4):836–46. doi:10.1007/s11095-017-2112-8.
   PubMed Web of Science ®Google Scholar
• Dandekar R, Ardekani AM. New model to predict the concentration-dependent viscosity of monoclonal antibody solutions. Mol Pharm. 2021;18(12):4385–92. PMID: 34699237. doi: 10.1021/acs.molpharmaceut.1c00561.
   PubMedGoogle Scholar
• Li Y, Roberts CJ. Lumry-eyring nucleated-polymerization model of protein aggregation kinetics. 2. Competing growth via condensation and chain polymerization. J Phys Chem B. 2009;113(19):7020–32. doi:10.1021/jp8083088.
   PubMed Web of Science ®Google Scholar
• Kim N, Remmele RLJ, Liu D, Razinkov VI, Fernandez EJ, Roberts CJ. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves fab unfolding and competing growth pathways mediated by pH and salt concentration. Biophys Chem. 2013;172:26–36. doi:10.1016/j.bpc.2012.12.004.
   PubMed Web of Science ®Google Scholar
• Woldeyes MA, Qi W, Razinkov VI, Furst EM, Roberts CJ. Temperature dependence of protein solution viscosity and protein–protein interactions: insights into the origins of high-viscosity protein solutions. Mol Pharmaceutics. 2020;17(12):4473–82. doi:10.1021/acs.molpharmaceut.0c00552.
   PubMed Web of Science ®Google Scholar
• Quigley A, Williams D. The second virial coefficient as a predictor of protein aggregation propensity: a self-interaction chromatography study. Eur J Pharm Biopharm. 2015;96:282–90. doi:10.1016/j.ejpb.2015.07.025.
   PubMed Web of Science ®Google Scholar
• Li Y, Ogunnaike BA, Roberts CJ. Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH, NaCl, and temperature for alpha-chymotrypsinogen A. J Pharm Sci. 2010;99(2):645–62. doi:10.1002/jps.21869.
   PubMed Web of Science ®Google Scholar
• Lilyestrom WG, Yadav S, Shire SJ, Scherer TM. Monoclonal antibody self-association, cluster formation, and rheology at high concentrations. J Phys Chem B. 2013;117(21):6373–84. doi:10.1021/jp4008152.
   PubMed Web of Science ®Google Scholar
• Pathak JA, Nugent S, Bender MF, Roberts CJ, Curtis RJ, Douglas JF. Comparison of huggins coefficients and osmotic second virial coefficients of buffered solutions of monoclonal antibodies. Polymers. 2021;13(4):601. doi:10.3390/polym13040601.
   PubMed Web of Science ®Google Scholar
• Roberts CJ, Das TK, Sahin E. Predicting solution aggregation rates for therapeutic proteins: approaches and challenges. Int J Pharm. 2011;418(2):318–33. A priori Performance Predictions. doi: 10.1016/j.ijpharm.2011.03.064.
   PubMedGoogle Scholar
• Woldeyes MA, Calero-Rubio C, Furst EM, Roberts CJ. Predicting protein interactions of concentrated globular protein solutions using colloidal models. J Phys Chem B. 2017;121(18):4756–67. doi:10.1021/acs.jpcb.7b02183.
   PubMed Web of Science ®Google Scholar
• Ghosh R, Calero-Rubio C, Saluja A, Roberts CJ. Relating protein–protein interactions and aggregation rates from low to high concentrations. J Pharm Sci. 2016;105(3):1086–96. doi:10.1016/j.xphs.2016.01.004.
   PubMed Web of Science ®Google Scholar
• Blanco MA, Perevozchikova T, Martorana V, Manno M, Roberts CJ. Protein–protein interactions in dilute to concentrated solutions: α-chymotrypsinogen in acidic conditions. J Phys Chem B. 2014;118(22):5817–31. doi:10.1021/jp412301h.
   PubMed Web of Science ®Google Scholar
• Barnett GV, Razinkov VI, Kerwin BA, Laue TM, Woodka AH, Butler PD, Perevozchikova T, Roberts CJ. Specific-ion effects on the aggregation mechanisms and protein-protein interactions for anti-streptavidin immunoglobulin gamma-1. J Phys Chem B. 2015;119(18):5793–804. doi:10.1021/acs.jpcb.5b01881.
   PubMed Web of Science ®Google Scholar
• Avramov I. Viscosity activation energy. Phys Chem Glas: Eur J Glass Sci Technol B. 2007;48:61–63.
   Web of Science ®Google Scholar
• Loskutov VV. Concentration dependence of the viscosity activation energy of aqueous ethylene glycol mixtures. J Solution Chem. 2021;50(3):427–42. doi:10.1007/s10953-021-01069-4.
   Web of Science ®Google Scholar
• Toplis MJ. Quantitative links between microscopic properties and viscosity of liquids in the system SiO2–Na2O. Chem Geol. 2001;174(1–3):321–31. doi:10.1016/S0009-2541(00)00323-5.
   Web of Science ®Google Scholar
• Tomar DS, Kumar S, Singh SK, Goswami S, Li L. Molecular basis of high viscosity in concentrated antibody solutions: strategies for high concentration drug product development. Mabs-austin. 2016;8(2):216–28. doi:10.1080/19420862.2015.1128606.
   PubMed Web of Science ®Google Scholar
• Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Prediction of aggregation prone regions of therapeutic proteins. J Phys Chem B. 2010;114(19):6614–24. doi:10.1021/jp911706q.
   PubMed Web of Science ®Google Scholar
• Lai P-K, Fernando A, Cloutier TK, Gokarn YR, Zhang J, Schwenger WJ, Chari RVJ, Calero-Rubio C, Trout BL. Machine learning applied to determine the molecular descriptors responsible for the viscosity behavior of concentrated therapeutic antibodies. Mol Pharmaceutics. 2021;2021(3):1167–75. doi:10.1021/acs.molpharmaceut.0c01073.
   Google Scholar
• Norman RA, Ambrosetti F, Bonvin AM, Colwell LJ, Kelm S, Kumar S, Krawczyk K. Computational approaches to therapeutic antibody design: established methods and emerging trends. Brief Bioinform. 2020;21(5):1549–67. doi:10.1093/bib/bbz095.
   PubMed Web of Science ®Google Scholar